259 related articles for article (PubMed ID: 1710067)
1. Alteration in age-specific risks for chromosomal trisomy by maternal serum alpha-fetoprotein and human chorionic gonadotropin screening.
Miller CH; O'Brien TJ; Chatelain S; Butler BB; Quirk JG
Prenat Diagn; 1991 Mar; 11(3):153-8. PubMed ID: 1710067
[TBL] [Abstract][Full Text] [Related]
2. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
3. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
[TBL] [Abstract][Full Text] [Related]
4. Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin.
Palomaki GE; Haddow JE; Knight GJ; Wald NJ; Kennard A; Canick JA; Saller DN; Blitzer MG; Dickerman LH; Fisher R
Prenat Diagn; 1995 Aug; 15(8):713-23. PubMed ID: 7479589
[TBL] [Abstract][Full Text] [Related]
5. First-trimester maternal serum alpha-fetoprotein and chorionic gonadotropin in aneuploid pregnancies.
Johnson A; Cowchock FS; Darby M; Wapner R; Jackson LG
Prenat Diagn; 1991 Jul; 11(7):443-50. PubMed ID: 1721715
[TBL] [Abstract][Full Text] [Related]
6. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
7. [Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes].
Hu Z; Liu X; Li L; Jia C; Li D; Liu R
Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):749-53. PubMed ID: 25537246
[TBL] [Abstract][Full Text] [Related]
8. Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha-fetoprotein, and age.
Crossley JA; Aitken DA; Connor JM
Prenat Diagn; 1991 Feb; 11(2):83-101. PubMed ID: 1712100
[TBL] [Abstract][Full Text] [Related]
9. Dependence of maternal serum [AFP]/[hCG] median ratios on age of gestation: comparison of trisomy 21 to euploid pregnancies.
Marcus-Braun N; Birk O; Manor E; Segal D; Harari G; Toma I; Shalev S; Borochowitz ZU; Yaron Y; Sharony R; Itzhaky D; Shtoyerman R; Appelman Z; Braun G
Prenat Diagn; 2009 Dec; 29(12):1130-4. PubMed ID: 19777489
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
Hsu JJ; Hsieh TT; Soong YK; Spencer K
Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
[TBL] [Abstract][Full Text] [Related]
11. Maternal smoking: age distribution, levels of alpha-fetoprotein and human chorionic gonadotrophin, and effect on detection of Down syndrome pregnancies in second-trimester screening.
Crossley JA; Aitken DA; Waugh SM; Kelly T; Connor JM
Prenat Diagn; 2002 Mar; 22(3):247-55. PubMed ID: 11920904
[TBL] [Abstract][Full Text] [Related]
12. Estimating the risk of a fetal autosomal trisomy at mid-trimester using maternal serum alpha-fetoprotein and age: a retrospective study of 142 pregnancies.
Zeitune M; Aitken DA; Crossley JA; Yates JR; Cooke A; Ferguson-Smith MA
Prenat Diagn; 1991 Nov; 11(11):847-57. PubMed ID: 1721713
[TBL] [Abstract][Full Text] [Related]
13. Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening.
Berry E; Aitken DA; Crossley JA; Macri JN; Connor JM
Prenat Diagn; 1995 Jun; 15(6):555-65. PubMed ID: 7544898
[TBL] [Abstract][Full Text] [Related]
14. Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin.
Palomaki GE; Knight GJ; Haddow JE; Canick JA; Saller DN; Panizza DS
Prenat Diagn; 1992 Nov; 12(11):925-30. PubMed ID: 1283634
[TBL] [Abstract][Full Text] [Related]
15. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: implications for screening for Down's syndrome.
Wald NJ; Cuckle HS; Densem JW; Stone RB
Br J Obstet Gynaecol; 1992 Jan; 99(1):51-3. PubMed ID: 1372176
[TBL] [Abstract][Full Text] [Related]
16. The use of free beta-hCG in antenatal screening for Down's syndrome.
Wald N; Densem J; Stone R; Cheng R
Br J Obstet Gynaecol; 1993 Jun; 100(6):550-7. PubMed ID: 7687460
[TBL] [Abstract][Full Text] [Related]
17. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
18. Effect of allowing for ethnic group in prenatal screening for Down's syndrome.
Watt HC; Wald NJ; Smith D; Kennard A; Densem J
Prenat Diagn; 1996 Aug; 16(8):691-8. PubMed ID: 8878277
[TBL] [Abstract][Full Text] [Related]
19. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
Wald NJ; Watt HC
Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18.
Chen Y; Chen Y; Ning W; Zhang W; Li L; Wang X; Yin Y; Zhang H
Sci Rep; 2022 Aug; 12(1):13605. PubMed ID: 35948592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
